Sun Pharma Advanced Research Company Ltd Hits 52-Week Low at Rs.116.2

Stock Price Movement and Market Context

On the day in question, SPARC's share price touched an intraday low of Rs.116.2, representing a 4.83% drop from the previous close and a 3.93% decline on the day overall. This move extended a two-day losing streak, during which the stock has fallen by 6.31%. The stock's performance notably lagged the Pharmaceuticals & Biotechnology sector, underperforming by 2.12% on the same day.

SPARC is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. This technical positioning underscores the stock’s bearish trend over multiple time frames.

Broader market conditions have also been unfavourable. The Nifty index closed at 23,151.10, down 488.05 points or 2.06%, with several indices including Nifty Media, Nifty Realty, and S&P Bse Dollex 30 hitting new 52-week lows on the same day. Mid-cap stocks, in particular, dragged the market lower, with the Nifty Midcap 100 index declining 2.65%. SPARC, classified as a small-cap stock, has been impacted by this overall market sentiment.

Financial Performance and Fundamental Concerns

SPARC’s financial metrics reveal persistent difficulties. The company reported a negative book value, indicating weak long-term fundamental strength. Over the past five years, net sales have declined at an annualised rate of 26.49%, while operating profit has decreased by 1.19% annually. This trend highlights a contraction in core business activities and profitability.

Recent quarterly results have been particularly unfavourable. The company declared very negative results for the quarter ended December 2025, with net sales falling 43.29% to Rs.8.45 crore compared to the previous four-quarter average. Profit after tax (PAT) for the latest six months stood at a loss of Rs.143.91 crore, deteriorating by 41.27%. Interest expenses have also risen, with the latest quarter recording the highest interest cost of Rs.8.78 crore, further pressuring earnings.

SPARC’s ability to service debt remains weak, as reflected in an average EBIT to interest ratio of -141.22, signalling that earnings before interest and tax are insufficient to cover interest obligations. This financial strain contributes to the stock’s classification as a strong sell, with a Mojo Score of 1.0 and a recent downgrade from Sell to Strong Sell on 1 Feb 2024.

Comparative Performance and Valuation

Over the last year, SPARC’s stock has generated a negative return of 4.63%, underperforming the Sensex, which gained 1.00% over the same period. The stock’s 52-week high was Rs.204.25, indicating a substantial decline of approximately 43% from that peak to the current low.

Valuation metrics suggest the stock is trading at risky levels relative to its historical averages. Despite a 34.2% rise in profits over the past year, the stock’s price performance has not reflected this improvement, indicating a disconnect between earnings and market valuation.

Long-term performance has also been below par, with the stock underperforming the BSE500 index over the last three years, one year, and three months. This persistent underperformance highlights challenges in regaining investor confidence and market traction.

Technical Indicators and Market Sentiment

Technical analysis of SPARC reveals predominantly bearish signals. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly charts. Bollinger Bands also indicate bearish trends across these time frames. Daily moving averages confirm a bearish stance, while the KST indicator shows a mildly bullish signal monthly but remains bearish weekly.

The Relative Strength Index (RSI) does not currently signal any strong momentum on weekly or monthly charts. Dow Theory assessments are mildly bearish on both weekly and monthly bases. On-balance volume (OBV) is mildly bearish weekly and shows no clear trend monthly. Collectively, these technical factors reinforce the downward pressure on the stock price.

Shareholding and Market Capitalisation

Promoters remain the majority shareholders of SPARC, maintaining significant control over the company’s direction. The stock is classified as a small-cap, which typically entails higher volatility and sensitivity to market fluctuations compared to larger-cap stocks.

Summary of Key Metrics

To summarise, SPARC’s key metrics as of 13 Mar 2026 include:

• New 52-week low price: Rs.116.2
• Day’s low intraday fall: -4.83%
• Two-day cumulative return: -6.31%
• Mojo Score: 1.0 (Strong Sell)
• Market cap grade: Small-cap
• Net sales decline (latest quarter): -43.29%
• PAT (latest six months): Rs.-143.91 crore, down 41.27%
• Interest expense (latest quarter): Rs.8.78 crore (highest recorded)
• EBIT to interest ratio (average): -141.22
• One-year stock return: -4.63%
• 52-week high: Rs.204.25

These figures illustrate the pressures faced by the company and the stock’s current valuation challenges amid a difficult market environment.

Market Environment and Sector Performance

The Pharmaceuticals & Biotechnology sector, to which SPARC belongs, has experienced mixed performance recently. While the sector itself has faced headwinds, SPARC’s underperformance relative to its peers and the broader market indices has been notable. The stock’s decline contrasts with some sector constituents that have maintained steadier valuations despite market volatility.

In the context of the broader market, the Nifty index’s position below its 50-day moving average, though with the 50DMA still above the 200DMA, suggests a cautious market stance. The mid-cap segment’s weakness, which has been a significant drag on the market, further compounds challenges for small-cap stocks like SPARC.

Conclusion

Sun Pharma Advanced Research Company Ltd’s fall to a 52-week low of Rs.116.2 reflects a combination of subdued financial results, weak fundamental indicators, and adverse technical signals. The stock’s sustained underperformance relative to benchmarks and sector peers underscores the challenges it faces in regaining momentum. Market conditions and valuation concerns continue to weigh on the share price, as evidenced by the recent downgrade to a Strong Sell rating and the company’s negative book value and profitability trends.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today